MET and glioma: Interestingly, the hepatocyte growth factor (HGF) has been identified recently as an additional ligand for NRP1, which potentiated HGF/c-Met signalling and promoted glioma progression and pancreatic cancer cell invasion (Hu et al, 2007; Matsushita et al, 2007).